Supplements News and Research

RSS

FDA issues safety labeling changes for female sexual dysfunction treatment

The U.S. Food and Drug Administration today issued a safety labeling change order to Sprout Pharmaceuticals for their drug, Addyi (flibanserin), that requires the company to revise important safety information that women and their health care professionals need to have when considering use of the drug.

12 Apr 2019

Living transplant donors also need long-term monitoring to prevent adverse events

While organ transplant recipients receive continual care as the end-stage treatment to their condition, attention also should be given to living donors, who can suffer from hypertension, diabetes and other disorders after donation, according to a study by researchers at UC San Francisco.

11 Apr 2019

FDA warns against using uncleared medical devices to assess or diagnose concussion

Today, the U.S. Food and Drug Administration is warning the public not to use medical devices marketed to consumers that claim to help assess, diagnose or manage head injury, including concussion, traumatic brain injury (TBI) or mild TBI.

11 Apr 2019

Value of dietary supplements in question

Millions of people around the world supplement their diet with vitamins and minerals to boost their health.

10 Apr 2019

FDA, EPA, and USDA announce strategy to address food waste

Today, as part of the Trump Administration's Winning on Reducing Food Waste Month, the U.S. Department of Agriculture, the U.S. Environmental Protection Agency, and the U.S. Food and Drug Administration announced the release of a federal interagency strategy to address food waste.

10 Apr 2019

$FDA approves new osteoporosis drug for postmenopausal women with high fracture risk$

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).

9 Apr 2019

Eight-year study identifies potential new way to treat extreme childhood food allergy

An eight-year hunt for the cells that drive the extreme childhood food allergy eosinophilic esophagitis has identified a potential new way to treat the disease while also raising questions about a dietary supplement often taken to reduce bowel inflammation.

9 Apr 2019

Excessive vitamin D intake causes man to develop kidney failure

A case study recently published in the Canadian Medical Association Journal has highlighted the danger of taking too many vitamin D supplements.

9 Apr 2019

Early nutritional intervention can help fight dementia

Trials have revealed significant advantages for patients who are treated with daily medical nutrient drinks, with 45 % less deterioration in the Clinical Dementia Rating Sum of Boxes.

9 Apr 2019

Supplements provide no additional health benefits, conclude researchers

A new study has found that using dietary supplements such as calcium and vitamin D do not prolong life expectancy, and may increase cancer risk.

9 Apr 2019

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.

9 Apr 2019

Dietary fiber could help prevent chronic obstructive pulmonary disease

Dietary fiber may be a new tool in the prevention of progressive lung disease, thanks to the production of anti-inflammatory short chain fatty acids, according to a new study by Australia's Priority Research Centre for Healthy Lungs at University of Newcastle, and the Centre for Inflammation, a partnership between The University of Technology Sydney and Centenary Institute.

5 Apr 2019

Patients on immunotherapies should consume more fiber, fewer probiotics

A new study has found that taking probiotics could drastically reduce the response of cancer patients to immunotherapy. Patients on a fiber-rich diet showed a five-fold increase in response.

5 Apr 2019

FDA extends indication of metastatic breast cancer treatment to include male patients

The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients.

5 Apr 2019

FDA and CBP collaborate to protect public health and safety

The U.S. Food and Drug Administration and the U.S. Customs and Border Protection leaders signed an agreement today to maximize inspection and detection capabilities in order to prevent illegal and harmful products entering the U.S. through the nation's International Mail Facilities and Ports of Entry that pose a threat to public health.

4 Apr 2019

Research identifies first case of a person without vitamin D binding protein

Research identifying the first case of a person living without the protein needed to bind and transport vitamin D in the bloodstream has been published in the New England Journal of Medicine.

4 Apr 2019

Dogs with hypothyroidism or that take omega-3 fatty acid may have lower risk of T-zone lymphoma

Dogs that receive omega-3 fatty acid supplements or have hypothyroidism may be less likely to develop T-zone lymphoma.

4 Apr 2019

Study provides insights on liver injury in men taking body building supplements

In a study reported in Alimentary Pharmacology & Therapeutics, 44 men with liver injury, attributed to over-the-counter bodybuilding supplements, experienced a uniform and distinctive pattern of signs and symptoms that were often prolonged, difficult to treat, and accompanied by disability and weight loss.

3 Apr 2019

FDA issues warning letters to four homeopathic firms for CGMP violations

The U.S. Food and Drug Administration today posted warning letters to four companies who produce homeopathic drug products for significant violations of current good manufacturing practice regulations, including a letter to King Bio Inc. of Asheville, N.C.

2 Apr 2019

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

29 Mar 2019